Literature DB >> 21670596

mTOR complex 2 signaling and functions.

Won Jun Oh1, Estela Jacinto.   

Abstract

The mechanistic target of rapamycin (mTOR) plays a central role in cellular growth and metabolism. mTOR forms two distinct protein complexes, mTORC1 and mTORC2. Much is known about the regulation and functions of mTORC1 due to availability of a natural compound, rapamycin, that inhibits this complex. Studies that define mTORC2 cellular functions and signaling have lagged behind. The development of pharmacological inhibitors that block mTOR kinase activity, and thereby inhibit both mTOR complexes, along with availability of mice with genetic knockouts in mTOR complex components have now provided new insights on mTORC2 function and regulation. Since prolonged effects of rapamycin can also disrupt mTORC2, it is worth re-evaluating the contribution of this less-studied mTOR complex in cancer, metabolic disorders and aging. In this review, we focus on recent developments on mammalian mTORC2 signaling mechanisms and its cellular and tissue-specific functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21670596      PMCID: PMC3322468          DOI: 10.4161/cc.10.14.16586

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  136 in total

1.  Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.

Authors:  Petra S Bachmann; Rocco G Piazza; Mary E Janes; Nicholas C Wong; Carwyn Davies; Angela Mogavero; Vivek A Bhadri; Barbara Szymanska; Greta Geninson; Vera Magistroni; Giovanni Cazzaniga; Andrea Biondi; Diego Miranda-Saavedra; Berthold Göttgens; Richard Saffery; Jeffrey M Craig; Glenn M Marshall; Carlo Gambacorti-Passerini; John E Pimanda; Richard B Lock
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

2.  mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis.

Authors:  Fei Zhang; Xiaofang Zhang; Menghui Li; Peng Chen; Bin Zhang; Hua Guo; Wenfeng Cao; Xiying Wei; Xuchen Cao; Xishan Hao; Ning Zhang
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

3.  mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide.

Authors:  Won Jun Oh; Chang-chih Wu; Sung Jin Kim; Valeria Facchinetti; Louis-André Julien; Monica Finlan; Philippe P Roux; Bing Su; Estela Jacinto
Journal:  EMBO J       Date:  2010-11-02       Impact factor: 11.598

4.  Prostaglandin E2 activates and utilizes mTORC2 as a central signaling locus for the regulation of mast cell chemotaxis and mediator release.

Authors:  Hye Sun Kuehn; Mi-Yeon Jung; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

Review 5.  mTOR: from growth signal integration to cancer, diabetes and ageing.

Authors:  Roberto Zoncu; Alejo Efeyan; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12-15       Impact factor: 94.444

6.  mTORC2 regulates neutrophil chemotaxis in a cAMP- and RhoA-dependent fashion.

Authors:  Lunhua Liu; Satarupa Das; Wolfgang Losert; Carole A Parent
Journal:  Dev Cell       Date:  2010-12-14       Impact factor: 12.270

7.  Steady-state kinetic and inhibition studies of the mammalian target of rapamycin (mTOR) kinase domain and mTOR complexes.

Authors:  Zhihua Tao; John Barker; Stone D-H Shi; Michael Gehring; Shaoxian Sun
Journal:  Biochemistry       Date:  2010-09-08       Impact factor: 3.162

8.  Akt and autophagy cooperate to promote survival of drug-resistant glioma.

Authors:  Qi-Wen Fan; Christine Cheng; Chris Hackett; Morri Feldman; Benjamin T Houseman; Theodore Nicolaides; Daphne Haas-Kogan; C David James; Scott A Oakes; Jayanta Debnath; Kevan M Shokat; William A Weiss
Journal:  Sci Signal       Date:  2010-11-09       Impact factor: 8.192

Review 9.  Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.

Authors:  Shomit Sengupta; Timothy R Peterson; David M Sabatini
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

10.  CK2 phospho-dependent binding of R2TP complex to TEL2 is essential for mTOR and SMG1 stability.

Authors:  Zuzana Horejsí; Hiroyuki Takai; Carrie A Adelman; Spencer J Collis; Helen Flynn; Sarah Maslen; J Mark Skehel; Titia de Lange; Simon J Boulton
Journal:  Mol Cell       Date:  2010-09-24       Impact factor: 17.970

View more
  242 in total

1.  High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1.

Authors:  Paige Yellen; Mahesh Saqcena; Darin Salloum; Jiangnan Feng; Angela Preda; Limei Xu; Vanessa Rodrik-Outmezguine; David A Foster
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

Review 2.  Deconvoluting mTOR biology.

Authors:  Jason D Weber; David H Gutmann
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Interferon γ (IFNγ) Signaling via Mechanistic Target of Rapamycin Complex 2 (mTORC2) and Regulatory Effects in the Generation of Type II Interferon Biological Responses.

Authors:  Barbara Kroczynska; Robert L Rafidi; Beata Majchrzak-Kita; Ewa M Kosciuczuk; Gavin T Blyth; Jacek Jemielity; Zofia Warminska; Diana Saleiro; Swarna Mehrotra; Ahmet Dirim Arslan; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2015-12-08       Impact factor: 5.157

4.  Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics.

Authors:  Jonathan B Olsen; Xing-Jun Cao; Bomie Han; Lisa Hong Chen; Alexander Horvath; Timothy I Richardson; Robert M Campbell; Benjamin A Garcia; Hannah Nguyen
Journal:  Mol Cell Proteomics       Date:  2016-01-10       Impact factor: 5.911

Review 5.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

6.  XPLN is an endogenous inhibitor of mTORC2.

Authors:  Nidhi Khanna; Yimin Fang; Mee-Sup Yoon; Jie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

7.  Pivotal role of mTORC2 and involvement of ribosomal protein S6 in cardioprotective signaling.

Authors:  Toshiyuki Yano; Marcella Ferlito; Angel Aponte; Atsushi Kuno; Tetsuji Miura; Elizabeth Murphy; Charles Steenbergen
Journal:  Circ Res       Date:  2014-02-20       Impact factor: 17.367

8.  mTOR Complex 2 Stabilizes Mcl-1 Protein by Suppressing Its Glycogen Synthase Kinase 3-Dependent and SCF-FBXW7-Mediated Degradation.

Authors:  Junghui Koo; Ping Yue; Xingming Deng; Fadlo R Khuri; Shi-Yong Sun
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

9.  Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.

Authors:  Qingming Dong; Gipsy Majumdar; Robert N O'Meally; Robert N Cole; Marshall B Elam; Rajendra Raghow
Journal:  Mol Cell Biochem       Date:  2019-09-20       Impact factor: 3.396

10.  Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.

Authors:  Meghan Morrison Joly; Donna J Hicks; Bayley Jones; Violeta Sanchez; Monica Valeria Estrada; Christian Young; Michelle Williams; Brent N Rexer; Dos D Sarbassov; William J Muller; Dana Brantley-Sieders; Rebecca S Cook
Journal:  Cancer Res       Date:  2016-04-25       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.